Screener
Janux Therapeutics JANX PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Janux Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:18 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338078
| Assets | June 30,2026 / (unaudited) | December 31,2025 |
|---|---|---|
| Prepaid expenses and other current assets | 12,275 | 9,320 |
| Total current assets | 983,337 | 975,887 |
| Restricted cash | 816 | 816 |
| Property and equipment, net | 3,260 | 3,852 |
| Operating lease right-of-use assets | 17,327 | 18,402 |
| Other long-term assets | 2,913 | 2,608 |
| Total assets | $1,007,653 | $1,001,565 |
| Liabilities and Stockholders’ Equity |
Item 1. Financial Statements.
FAQ
- What is Janux Therapeutics's PP&E (net)?
- Janux Therapeutics (JANX) reported PP&E (net) of $3.26M in Q2 2026.
- How has Janux Therapeutics's PP&E (net) changed year-over-year?
- Janux Therapeutics's PP&E (net) decreased by 30.5% year-over-year, from $4.69M to $3.26M.
- What is the long-term trend for Janux Therapeutics's PP&E (net)?
- Over 5 years (2020 to 2025), Janux Therapeutics's PP&E (net) has grown at a 90.1% compound annual growth rate (CAGR), from $155K to $3.85M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Janux Therapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude